vs
Qorvo, Inc.（QRVO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Qorvo, Inc.的季度营收约是Royalty Pharma plc的1.6倍（$993.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 16.5%，领先17.9%），Qorvo, Inc.同比增速更快（8.4% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 2.7%）
Qorvo是一家美国跨国企业，专注于无线、有线及电源市场相关产品的研发与供应。该公司由TriQuint半导体与RF Micro Devices合并而来，合并计划于2014年公布，2015年1月1日正式完成，在纳斯达克挂牌上市，股票代码QRVO，原实行双总部制，2016年中起将北卡罗来纳州基地作为总部所在地。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
QRVO vs RPRX — 直观对比
营收规模更大
QRVO
是对方的1.6倍
$622.0M
营收增速更快
QRVO
高出3.6%
4.8%
净利率更高
RPRX
高出17.9%
16.5%
两年增速更快
RPRX
近两年复合增速
2.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $993.0M | $622.0M |
| 净利润 | $164.1M | $214.2M |
| 毛利率 | 46.7% | — |
| 营业利润率 | 19.4% | 62.4% |
| 净利率 | 16.5% | 34.4% |
| 营收同比 | 8.4% | 4.8% |
| 净利润同比 | 297.5% | 2.9% |
| 每股收益（稀释后） | $1.75 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收QRVORPRX
| Q4 25 | $993.0M | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $818.8M | $578.7M | ||
| Q1 25 | $869.5M | $568.2M | ||
| Q4 24 | $916.3M | $593.6M | ||
| Q3 24 | $1.0B | $564.7M | ||
| Q2 24 | $886.7M | $537.3M | ||
| Q1 24 | $941.0M | $568.0M |
净利润QRVORPRX
| Q4 25 | $164.1M | $214.2M | ||
| Q3 25 | $119.6M | $288.2M | ||
| Q2 25 | $25.6M | $30.2M | ||
| Q1 25 | $31.4M | $238.3M | ||
| Q4 24 | $41.3M | $208.2M | ||
| Q3 24 | $-17.4M | $544.0M | ||
| Q2 24 | $414.0K | $102.0M | ||
| Q1 24 | $2.7M | $4.8M |
毛利率QRVORPRX
| Q4 25 | 46.7% | — | ||
| Q3 25 | 47.0% | — | ||
| Q2 25 | 40.5% | — | ||
| Q1 25 | 42.2% | — | ||
| Q4 24 | 42.7% | — | ||
| Q3 24 | 42.6% | — | ||
| Q2 24 | 37.5% | — | ||
| Q1 24 | 40.6% | — |
营业利润率QRVORPRX
| Q4 25 | 19.4% | 62.4% | ||
| Q3 25 | 14.9% | 70.1% | ||
| Q2 25 | 3.7% | 36.3% | ||
| Q1 25 | 3.2% | 94.0% | ||
| Q4 24 | 5.8% | 60.9% | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.5% | 50.2% | ||
| Q1 24 | 3.2% | -13.0% |
净利率QRVORPRX
| Q4 25 | 16.5% | 34.4% | ||
| Q3 25 | 11.3% | 47.3% | ||
| Q2 25 | 3.1% | 5.2% | ||
| Q1 25 | 3.6% | 41.9% | ||
| Q4 24 | 4.5% | 35.1% | ||
| Q3 24 | -1.7% | 96.3% | ||
| Q2 24 | 0.0% | 19.0% | ||
| Q1 24 | 0.3% | 0.8% |
每股收益（稀释后）QRVORPRX
| Q4 25 | $1.75 | $0.49 | ||
| Q3 25 | $1.28 | $0.67 | ||
| Q2 25 | $0.27 | $0.07 | ||
| Q1 25 | $0.33 | $0.55 | ||
| Q4 24 | $0.43 | $0.46 | ||
| Q3 24 | $-0.18 | $1.21 | ||
| Q2 24 | $0.00 | $0.23 | ||
| Q1 24 | $0.04 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | $618.7M |
| 总债务越低越好 | $1.5B | $9.0B |
| 股东权益账面价值 | $3.7B | $9.7B |
| 总资产 | $6.2B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.42× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资QRVORPRX
| Q4 25 | $1.3B | $618.7M | ||
| Q3 25 | $1.1B | $938.9M | ||
| Q2 25 | $1.2B | $631.9M | ||
| Q1 25 | $1.0B | $1.1B | ||
| Q4 24 | $769.4M | $929.0M | ||
| Q3 24 | $1.1B | $950.1M | ||
| Q2 24 | $1.1B | $1.8B | ||
| Q1 24 | $1.0B | $843.0M |
总债务QRVORPRX
| Q4 25 | $1.5B | $9.0B | ||
| Q3 25 | $1.5B | $8.9B | ||
| Q2 25 | $1.5B | $8.0B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.5B | $7.6B | ||
| Q3 24 | $1.5B | $7.6B | ||
| Q2 24 | $1.5B | $7.6B | ||
| Q1 24 | $1.5B | $6.1B |
股东权益QRVORPRX
| Q4 25 | $3.7B | $9.7B | ||
| Q3 25 | $3.5B | $9.6B | ||
| Q2 25 | $3.4B | $9.5B | ||
| Q1 25 | $3.4B | $9.8B | ||
| Q4 24 | $3.4B | $10.3B | ||
| Q3 24 | $3.4B | $10.3B | ||
| Q2 24 | $3.5B | $9.8B | ||
| Q1 24 | $3.6B | $9.9B |
总资产QRVORPRX
| Q4 25 | $6.2B | $19.6B | ||
| Q3 25 | $6.1B | $19.3B | ||
| Q2 25 | $6.0B | $18.3B | ||
| Q1 25 | $5.9B | $17.6B | ||
| Q4 24 | $6.0B | $18.2B | ||
| Q3 24 | $6.5B | $18.0B | ||
| Q2 24 | $6.4B | $17.7B | ||
| Q1 24 | $6.6B | $16.1B |
负债/权益比QRVORPRX
| Q4 25 | 0.42× | 0.92× | ||
| Q3 25 | 0.44× | 0.93× | ||
| Q2 25 | 0.45× | 0.84× | ||
| Q1 25 | 0.46× | 0.78× | ||
| Q4 24 | 0.46× | 0.74× | ||
| Q3 24 | 0.45× | 0.74× | ||
| Q2 24 | 0.44× | 0.78× | ||
| Q1 24 | 0.44× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $265.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $236.9M | — |
| 自由现金流率自由现金流/营收 | 23.9% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 1.62× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $595.2M | — |
8季度趋势，按日历期对齐
经营现金流QRVORPRX
| Q4 25 | $265.4M | $827.1M | ||
| Q3 25 | $84.0M | $702.6M | ||
| Q2 25 | $182.9M | $364.0M | ||
| Q1 25 | $199.2M | $596.1M | ||
| Q4 24 | $214.1M | $742.5M | ||
| Q3 24 | $127.8M | $703.6M | ||
| Q2 24 | $81.1M | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流QRVORPRX
| Q4 25 | $236.9M | — | ||
| Q3 25 | $42.2M | — | ||
| Q2 25 | $145.4M | — | ||
| Q1 25 | $170.7M | — | ||
| Q4 24 | $176.2M | — | ||
| Q3 24 | $94.8M | — | ||
| Q2 24 | $42.9M | — | ||
| Q1 24 | — | — |
自由现金流率QRVORPRX
| Q4 25 | 23.9% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 19.6% | — | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 4.8% | — | ||
| Q1 24 | — | — |
资本支出强度QRVORPRX
| Q4 25 | 2.9% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | — | — |
现金转化率QRVORPRX
| Q4 25 | 1.62× | 3.86× | ||
| Q3 25 | 0.70× | 2.44× | ||
| Q2 25 | 7.15× | 12.06× | ||
| Q1 25 | 6.35× | 2.50× | ||
| Q4 24 | 5.19× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 195.86× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QRVO
| ACG | $690.8M | 70% |
| HPA | $190.9M | 19% |
| CSG | $111.3M | 11% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
